Loading chat...
IN SB0146
Bill
Status
1/3/2019
Primary Sponsor
James Merritt
Click for details
AI Summary
-
All controlled substance prescriptions must be issued electronically after June 30, 2020, with violations constituting a Class B infraction
-
Prescribers must complete 3 additional hours of continuing education every 2 years on opioid prescribing to maintain authority to prescribe opioid medications
-
Failure to complete the required opioid prescribing education constitutes a Class B infraction
-
The Medical Licensing Board of Indiana must study and report by November 1, 2019, on whether a waiver process is needed for prescribers lacking electronic prescribing capability
-
If a waiver is deemed necessary, the board's recommendation must specify the administering agency, qualifying reasons, waiver duration, and program length
Legislative Description
Prescribing of controlled substance. Requires that a controlled substance prescription be issued electronically after June 30, 2020, and establishes a Class B infraction for a prescriber who fails to comply. Requires a prescriber to obtain three hours of continuing education every two years on the prescribing of opioid medication in order to continue issuing prescriptions for opioid medication, and establishes a Class B infraction for failure to comply. Requires the medical licensing board of Indiana to study and determine, before November 1, 2019, whether a waiver is necessary for the electronic prescription requirement and to report back to the general assembly. Sets forth requirements for the report.
Last Action
First reading: referred to Committee on Health and Provider Services
1/3/2019